VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Gentium S.p.A. (NASDAQ:GENT) today announced that its lead product, Defibrotide, will be highlighted in a presentation made by Professor Ernst Holler in a lecture entitled, “Defibrotide: Mechanism of action and clinical application.” The lecture will be given in the session “Stem cell transplantation and homeostasis” on Saturday, February 24, 2007, at 9:20 a.m. (local time) at the 51st Meeting of the German Society for Thrombosis and Hemostasis being held from February 22-24, 2007 in Dresden, Germany. For more details on the congress, please visit http://www.cpb.de/congress/index.php?id=675&L=0.
